Although public hospitals are nominally evenly spread across the country. Current efforts to give better access to medicines are complicated by concerns that the low prices of some medicines compared to other EU countries may lead to parallel exports, undermining access within Romania In response, the Ministry of Health has obtained EU approval to stop parallel exports of vaccines for a limited period (2017). There is also some anecdotal evidence that cost is creating a major obstacle to access for certain new treatments. Reforms are expected to reduce pharmaceutical expenditure as well as to improve overall health system funding.